Read + Share
Carpentieri GB, Goncalves SEAB, Casagrande MZ, Mourad WM, et al. SGLT2 Inhibition with Empagliflozin as a Possible Therapeutic Option for
Postprandial Hypoglycemia After Bariatric Surgery. Obes Surg 2022;32:2664-2671.
PMID: 35674979
|
 |
|
Carpentieri GB, Goncalves SEAB, Casagrande MZ, Mourad WM, et al. SGLT2 Inhibition with Empagliflozin as a Possible Therapeutic Option for
Postprandial Hypoglycemia After Bariatric Surgery. Obes Surg 2022;32:2664-2671.
PMID: 35674979
|
|
|
|